Triterpenoids CDDO and CDDO-EA Inhibit the Replication of Hepatitis B Virus by Modulating Nucleocapsid Assembly
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms27010300 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Qiang Gao und 10 weiteren Autor:innen. Beteiligte Einrichtung: CAMS Key Laboratory of Antiviral Drug Research, Beijing Key Laboratory of Technology and Application for Anti-Infective New Drugs Research and Develo…. Hauptthemen laut MEDLINE: Hepatitis B virus, Oleanolic Acid, Virus Replication, Antiviral Agents. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Drug Innovation Major Project, CAMS Innovation Fund for Medical Sciences.
Abstract (Originalsprache)
Chronic hepatitis B virus (HBV) infection remains a global public health challenge, and the currently approved medications can not achieve a cure. Synthetic triterpenoids have shown promising therapeutic potential for liver pathologies. In our search for novel antiviral agents against HBV, we found that two triterpenoids, 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO) and CDDO-ethyl amide (CDDO-EA), significantly inhibited HBV DNA replication. Further mechanistic investigation indicated that these two compounds did not significantly alter the levels of total HBV pgRNA, but dramatically reduced extracellular pgRNA and intracellular encapsidated pgRNA in a dose-dependent manner. Western blot analysis indicated minimal effects on core protein expression. Interestingly, using a particle gel assay, we observed that CDDO and CDDO-EA promoted the formation of empty capsids with no alteration in electrophoretic mobility. Moreover, we demonstrated that both compounds modulated the phosphorylation status of the core protein. Further cellular thermal shift assay (CETSA), surface plasmon resonance (SPR) assay, and molecular docking analyses collectively suggested that CDDO and CDDO-EA could bind directly to the dimer–dimer interfaces of HBV core protein. Finally, a synergistic effect was observed between CDDO-EA and lamivudine in reducing intracellular and extracellular HBV DNA levels. Our findings indicate that triterpenoids CDDO and CDDO-EA are new mechanistically type of HBV capsid assembly modulators and warranted for further development as lead compounds against HBV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CAMS Key Laboratory of Antiviral Drug Research, Beijing Key Laboratory of Technology and Application for Anti-Infective New Drugs Research and Development, NHC Key Laboratory of Biotechnology for Microbial Drugs, Instit…
- State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
ORCID-Profile: Lu Yang, Huiqiang Wang
Förderung
- National Natural Science Foundation of China
- Drug Innovation Major Project
- CAMS Innovation Fund for Medical Sciences
- National Science and Technology Infrastructure of China
- National Science and Technology Infra-structure of China
Zitieren
APA
Gao, Q., Yang, G., Wang, Y., Yang, L., Hu, J., Wang, H., Yan, H., Wang, K., Wu, S., Li, Y., & Jiang, J. (2025). Triterpenoids CDDO and CDDO-EA Inhibit the Replication of Hepatitis B Virus by Modulating Nucleocapsid Assembly. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27010300
Vancouver
Gao Q, Yang G, Wang Y, Yang L, Hu J, Wang H, et al. Triterpenoids CDDO and CDDO-EA Inhibit the Replication of Hepatitis B Virus by Modulating Nucleocapsid Assembly. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms27010300
BibTeX
@article{Gao2025,
author = {Gao, Qiang and Yang, Ge and Wang, Ya and Yang, Lu and Hu, Jin and Wang, Huiqiang and Yan, Haiyan and Wang, Kun and Wu, Shuo and Li, Yuhuan and Jiang, Jiandong},
title = {Triterpenoids CDDO and CDDO-EA Inhibit the Replication of Hepatitis B Virus by Modulating Nucleocapsid Assembly},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms27010300}
}
EUVIMED